Physician profile

Kevin Traub

Pittsburgh, PA

NPI 1861491201

$2,829.79

in general payments reported to CMS, 2019-2025

18 companies · $739 in 2025

The $739 reported for 2025 was more than what 84% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,288.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sumitomo Pharma America, INC. $666.43 2023-2025 Orgovyx
Myovant Sciences INC. $477.28 2021-2022
Teleflex LLC $333.00 2021-2022
Pfizer INC. $307.03 2019-2024
Astellas Pharma US INC $207.36 2019-2022
Bioprotect Medical, INC. $197.56 2025 Bioprotect Balloon Implant System
Procept Biorobotics Corporation $190.00 2025
Calyxo, INC. $146.98 2025 Cvac Aspiration System
Abbvie INC. $136.99 2019-2023 Lupron Depot
Boston Scientific Corporation $36.51 2019-2024 Spaceoar System
Palette Life Sciences, INC. $35.80 2022
Olympus America INC. $25.32 2022
Medtronic USA, INC. $16.78 2019
Ethicon US, LLC $16.00 2019
Janssen Biotech, INC. $14.19 2019
Show all 17 companies
CompanyGeneral paymentsYearsTop products
Allergan, INC. $11.69 2020
Endo Pharmaceuticals INC. $10.87 2019

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Kevin Traub

$2,829.79

in general payments reported 2019-2025

Years
2019-2025
Top company
Sumitomo Pharma America, INC.
Context
The $739 reported for 2025 was more than what 84% of providers received nationally.

https://glasscript.com/doctor/175593/kevin-traub

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.